Matches in Wikidata for { <http://www.wikidata.org/entity/Q87932076> ?p ?o ?g. }
Showing items 1 to 45 of
45
with 100 items per page.
- Q87932076 description "assaig clínic" @default.
- Q87932076 description "clinical trial" @default.
- Q87932076 description "clinical trial" @default.
- Q87932076 description "clinical trial" @default.
- Q87932076 description "clinical trial" @default.
- Q87932076 description "ensaio clínico" @default.
- Q87932076 description "ensayo clínico" @default.
- Q87932076 description "ensayu clínicu" @default.
- Q87932076 description "essai clinique" @default.
- Q87932076 description "klinisch onderzoek" @default.
- Q87932076 description "клінічне випробування" @default.
- Q87932076 description "կլինիկական փորձարկում" @default.
- Q87932076 name "Study of TBio-6517, Given Intratumorally, Alone or in Combination With Pembrolizumab, in Solid Tumors" @default.
- Q87932076 name "Study of TBio-6517, Given Intratumorally, Alone or in Combination With Pembrolizumab, in Solid Tumors" @default.
- Q87932076 type Item @default.
- Q87932076 label "Study of TBio-6517, Given Intratumorally, Alone or in Combination With Pembrolizumab, in Solid Tumors" @default.
- Q87932076 label "Study of TBio-6517, Given Intratumorally, Alone or in Combination With Pembrolizumab, in Solid Tumors" @default.
- Q87932076 prefLabel "Study of TBio-6517, Given Intratumorally, Alone or in Combination With Pembrolizumab, in Solid Tumors" @default.
- Q87932076 prefLabel "Study of TBio-6517, Given Intratumorally, Alone or in Combination With Pembrolizumab, in Solid Tumors" @default.
- Q87932076 P1132 Q87932076-7E29B9D3-B070-44BF-AEEE-D0B84EA910D9 @default.
- Q87932076 P1476 Q87932076-22AF568B-FB33-4CD2-A887-9679144021E4 @default.
- Q87932076 P17 Q87932076-1A0DE3EE-F4A4-499F-8D41-98A5E20BB5CE @default.
- Q87932076 P1813 Q87932076-E1D9CB6D-73A5-4EBC-972E-D59E32686D3B @default.
- Q87932076 P2899 Q87932076-B8117278-E107-4155-A955-4D43F62A8E46 @default.
- Q87932076 P3098 Q87932076-B8D5FDEA-9E2A-47C2-9F28-B395EDF34FDA @default.
- Q87932076 P31 Q87932076-B5A1457D-75C2-4069-9E61-B528691D23F3 @default.
- Q87932076 P4844 Q87932076-45962F66-FD59-4D40-999B-FE419C230BA4 @default.
- Q87932076 P580 Q87932076-F729136D-A7D9-489B-9358-3C08C11B46B7 @default.
- Q87932076 P582 Q87932076-B98D800C-A52B-4E9F-85EF-8B1E6C7D0DC0 @default.
- Q87932076 P6099 Q87932076-3D627643-71A4-4868-A642-69703B29F6FC @default.
- Q87932076 P6099 Q87932076-BF57360A-9282-448E-BBB4-C1376903F9AD @default.
- Q87932076 P8363 Q87932076-D2ADA760-EF55-450E-A6BE-13E290AC2367 @default.
- Q87932076 P1132 "+84" @default.
- Q87932076 P1476 "A Phase 1/2a, Multicenter, Open-label Trial of TBio-6517, an Oncolytic Vaccinia Virus, Administered by Intratumoral Injection, Alone and in Combination With Pembrolizumab, in Patients With Advanced Solid Tumors" @default.
- Q87932076 P17 Q30 @default.
- Q87932076 P1813 "RAPTOR" @default.
- Q87932076 P2899 "+18" @default.
- Q87932076 P3098 "NCT04301011" @default.
- Q87932076 P31 Q30612 @default.
- Q87932076 P4844 Q13896859 @default.
- Q87932076 P580 "2020-04-20T00:00:00Z" @default.
- Q87932076 P582 "2022-08-20T00:00:00Z" @default.
- Q87932076 P6099 Q42824440 @default.
- Q87932076 P6099 Q5452194 @default.
- Q87932076 P8363 Q78089383 @default.